Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Non Operating Income: 2021-2025

Historic Non Operating Income for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$89.1 million.

  • Core Scientific's Non Operating Income rose 78.47% to -$89.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$601.4 million, marking a year-over-year increase of 52.61%. This contributed to the annual value of -$1.3 billion for FY2024, which is 408.29% down from last year.
  • Latest data reveals that Core Scientific reported Non Operating Income of -$89.1 million as of Q3 2025, which was up 90.21% from -$910.4 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Non Operating Income ranged from a high of $623.5 million in Q1 2025 and a low of -$910.4 million during Q2 2025.
  • Over the past 3 years, Core Scientific's median Non Operating Income value was -$89.1 million (recorded in 2025), while the average stood at -$175.1 million.
  • In the last 5 years, Core Scientific's Non Operating Income tumbled by 18,139.83% in 2022 and then skyrocketed by 2,074.00% in 2024.
  • Core Scientific's Non Operating Income (Quarterly) stood at -$25.2 million in 2021, then skyrocketed by 813.49% to $179.7 million in 2022, then plummeted by 210.88% to -$199.3 million in 2023, then declined by 13.09% to -$225.4 million in 2024, then spiked by 78.47% to -$89.1 million in 2025.
  • Its last three reported values are -$89.1 million in Q3 2025, -$910.4 million for Q2 2025, and $623.5 million during Q1 2025.